Screener
Corcept Therapeutics CORT Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory | 13,185 | 12,868 |
| Prepaid expenses and other current assets | 41,374 | 40,658 |
| Total current assets | 439,676 | 485,464 |
| Strategic inventory | 18,956 | 11,094 |
| Operating lease right-of-use asset | 6,860 | 4,583 |
| Property and equipment, net | 5,133 | 1,890 |
| Long-term marketable securities | 236,451 | 160,270 |
| Other assets | 2,946 | 5,153 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's inventories?
- Corcept Therapeutics (CORT) reported inventories of $18.96M in Q2 2026.
- How has Corcept Therapeutics's inventories changed year-over-year?
- Corcept Therapeutics's inventories increased by 137.2% year-over-year, from $7.99M to $18.96M.
- What is the long-term trend for Corcept Therapeutics's inventories?
- Over 5 years (2020 to 2025), Corcept Therapeutics's inventories has grown at a -7.3% compound annual growth rate (CAGR), from $16.25M to $11.09M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Corcept Therapeutics's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude